Try our Advanced Search for more refined results
Competition
-
January 26, 2026
Generics Makers Fight Cert. In Cholesterol Drug Pricing MDL
Generic-drug makers sought to defeat a bid to certify proposed classes comprising thousands of pharmacies that indirectly purchased and resold generics at the center of sprawling price-fixing litigation, telling a Pennsylvania federal court Monday that certification would result in an "unmanageable trial."
-
January 26, 2026
Truck Makers Say Calif. Delaying 'Clean Trucks Pact' Fight
Heavy-duty truck manufacturers on Monday accused California officials of trying to delay litigation over a 2023 agreement that would saddle manufacturers with stringent state emissions standards and stiff penalties for noncompliance in the coming years.
-
January 26, 2026
Fubo Subscribers Defend Streaming Rate Suit Against Disney
A proposed class of Fubo subscribers is opposing a bid from Disney to force them to arbitrate their claims in an antitrust case alleging streaming services pay inflated rates to carry ESPN and other sports channels.
-
January 26, 2026
Google Targets Publishers' Ad Tech Claims
Google asked a New York federal judge to cut out a wide swath of antitrust claims from multidistrict litigation targeting its advertising placement technology dominance, assailing in separate briefs allegations from a class of website publishers and from the Daily Mail and Gannett.
-
January 26, 2026
9th Circ. Pauses Discovery Order In UFC Wage Suits
A Ninth Circuit panel temporarily paused a Nevada federal court's discovery order in wage suppression lawsuits against UFC after the mixed martial arts organization said the order violated attorney-client privilege and the First Amendment.
-
January 26, 2026
Amex Seeks First Approval Of $17M Antisteering Settlement
American Express Co. has asked a New York federal judge to grant the first green light to a $17.5 million settlement reached with consumers who claimed the credit card company's so-called antisteering rules caused non-Amex cardholders to pay higher charges, after a New York federal jury ordered Amex to pay $12 million to one class of consumers.
-
January 26, 2026
Novo Nordisk Faces Class Claims Over GLP-1 Patent Tactics
A South Carolina drug company has launched a proposed class action against major pharmaceutical company Novo Nordisk, alleging it engaged in anticompetitive behavior to prolong its monopoly against generic competition for the GLP-1 drug Victoza.
-
January 26, 2026
Radio Co. Says Letting Nielsen Resume Data Tying Hurts Biz
Cumulus Media has urged the Second Circuit not to lift a New York federal judge's order blocking Nielsen from conditioning access to its nationwide radio ratings data on the purchase of local market data while the ratings company appeals the ruling.
-
January 26, 2026
Remote Discovery Tech Co. Alleges Fraud In Del. Suit
A tech company that developed self-service applications for remote data collection from smartphones has launched a seven-count suit in Delaware's Court of Chancery accusing a product reseller of copying the application's functions and features and marketing competing versions.
-
January 26, 2026
Calif. Gaming Org. Fights Tribe's Bid To Join $700M Casino Suit
A District of Columbia federal judge on Monday granted the California Gaming Association's amicus brief bid to oppose a California Indian tribe's potential dismissal motion against another tribe's fight with the federal government over a $700 million casino project in Vallejo, California.
-
January 23, 2026
Pro Swimming League Wins Antitrust Trial. Its Prize? $1
A California federal jury has determined that World Aquatics illegally boycotted International Swimming League events in violation of federal antitrust law, but awarded just $1 in damages, in a verdict returned Friday.
-
January 23, 2026
Mich. AG Sues Major Oil Co. 'Cartel' Amid Fight With DOJ
Michigan Attorney General Dana Nessel filed an antitrust suit in federal court against BP, Shell, Chevron, Exxon and the American Petroleum Institute on Friday, claiming they conspired to maintain market dominance by steering money away from renewable energy and using a bevy of other tactics including intimidation and information suppression.
-
January 23, 2026
CLO Investors Accused Of Rigging Rates In Shift From Libor
Major equity investors in collateralized loan obligations have been sued in Connecticut federal court over claims that they colluded to force corporate leveraged-loan borrowers to accept higher interest rates during the phaseout of the London Interbank Offered Rate, or Libor.
-
January 23, 2026
High Court Unlikely To Walk Back MLB's Antitrust Privilege
Baseball's status as the lone sport exempt from federal antitrust laws is likely to evade U.S. Supreme Court scrutiny, with legal experts saying that only an extraordinary challenge could make justices even consider it.
-
January 23, 2026
Providers Oppose Credit Bureaus' Medical Debt Appeal
A proposed class of medical providers and collection agencies accusing Equifax, Experian and TransUnion of colluding to exclude medical debt under $500 from consumer credit reports is opposing a bid by the credit bureaus to expedite an appeal of a ruling that denied dismissal of the claims.
-
January 23, 2026
NCAA Player Can't Rush Eligibility Order, Judge Says
A Florida federal judge recommended denying a request by a university basketball player to expedite an injunction allowing her to play a fifth season, finding the National College Athletic Association wasn't inconsistent with denying eligibility.
-
January 23, 2026
Heart Valve Deal Was Blocked Over Innovation Concerns
The D.C. federal court ruling earlier this month that upended a deal for Edwards Lifesciences Corp. to purchase JenaValve Technology Inc. was based on concerns that the deal would reduce innovation by eliminating competition for a heart valve treatment that's still being developed, according to a ruling unsealed on Friday by the judge who issued it.
-
January 23, 2026
$200M Sun, Taro Generics Deal Gets Final OK
A Pennsylvania federal judge granted final approval Friday for a $200 million deal resolving employee benefits plans' claims against Sun Pharmaceutical and Taro Pharmaceuticals in the sprawling price-fixing litigation against generic-drug makers, while again ensuring the claims from dozens of state attorneys general remain untouched by the settlement.
-
January 23, 2026
How Data, Pies And An FTC Twist Helped Close A $13B Deal
For the Willkie Farr & Gallagher LLP attorneys advising The Interpublic Group of Companies Inc. on its blockbuster merger with Omnicom Group Inc., reaching the finish line came with an unusual antitrust concession: a Federal Trade Commission agreement aimed at the politics of ad placement.
-
January 23, 2026
News Rating Org. Latest To Fight 'Ideological' FTC Subpoena
News rating organization NewsGuard became the latest group to challenge a Federal Trade Commission subpoena looking for censorship of conservative viewpoints, asking the agency to quash information demands it said was born of FTC Chairman Andrew Ferguson's "ideologically motivated effort to censor and otherwise discriminate" against it.
-
January 23, 2026
Commerce Hits Chinese Slag Pots With Duties
The U.S. Department of Commerce hit imported slag pots from China with countervailing and antidumping duties Friday after the U.S. International Trade Commission had found the dumped and subsidized imports were causing material injury to domestic industry.
-
January 23, 2026
Full 9th Circ. Won't Review Google Maps Antitrust Case
The full Ninth Circuit won't reconsider an appellate panel's recent decision refusing to revive a proposed antitrust class action alleging Google's terms suppresses competition by locking out rival maps products and jacking up developer costs up to 1,400%, according to a brief order issued Thursday.
-
January 23, 2026
FCC Considers Revoking Texas Radio Station Licenses
The Federal Communications Commission has designated for hearing a proposed transfer of control involving three Texas radio stations, citing substantial questions about unauthorized foreign control, misrepresentations, and lack of candor that could ultimately lead to license revocation.
-
January 23, 2026
X Can't Access OpenAI Source Code In Antitrust Suit
A Texas federal court will not force OpenAI Inc. to hand over its source code in an antitrust case from Elon Musk's X Corp. over the artificial intelligence company's deal to integrate ChatGPT on Apple devices.
-
January 23, 2026
More Push In The 'Push-Pull' As DOJ Targets 'Gamesmanship'
The U.S. Department of Justice continues to build its task force targeting "gamesmanship" that it says BigLaw attorneys for major companies, especially technology platforms, are using to obstruct antitrust investigations — an effort that has been welcomed by some practitioners and questioned by others.
Expert Analysis
-
Series
Quilting Makes Me A Better Lawyer
Turning intricate patterns of fabric and thread into quilts has taught me that craftsmanship, creative problem-solving and dedication to incremental progress are essential to creating something lasting that will help another person — just like in law, says Veronica McMillan at Kramon & Graham.
-
A Look At Robinson-Patman Enforcement In The MLM Industry
The Federal Trade Commission's recent focus on price discrimination in high-profile speeches and litigation suggests a renewed interest around Robinson-Patman Act enforcement, particularly in multilevel marketing, making it an apt time for direct sellers to audit their pricing, say Katrina Eash at Winston & Strawn and Juliet Belling Warren and Branko Jovanovic at Edgeworth Economics.
-
What 2 Profs Noticed As Transactional Law Students Used AI
After a semester using generative artificial intelligence tools with students in an entrepreneurship law clinic, we came away with numerous observations about the opportunities and challenges such tools present to new transactional lawyers, say professors at Cornell Law School.
-
State AGs Are Turning Up The Antitrust Heat On ESG Actions
Recent antitrust developments from red state attorneys general continue a trend of environmental, social and governance scrutiny, and businesses exposed to these areas should conduct close examinations of strategy and potential material risk, say attorneys at Morgan Lewis.
-
Rebuttal
BigLaw Settlements Should Not Spur Ethics Deregulation
A recent Law360 op-ed argued that loosening law firm funding restrictions would make BigLaw firms less inclined to settle with the Trump administration, but deregulating legal financing ethics may well prove to be not merely ineffective, but counterproductive, says Laurel Kilgour at the American Economic Liberties Project.
-
Opinion
8th Circ. Should Reaffirm False Commercial Speech's Nature
The Eighth Circuit in Goldfinch Laboratory v. Iowa Pathology Associates should assert that false commercial speech is not categorically immune from antitrust scrutiny, says Daniel Graulich at the Federal Trade Commission.
-
How Big Pharma Has Responded To FTC Delisting Demands
Looking at some statistics concerning how pharmaceutical companies have responded to the Federal Trade Commission's recent challenges to Orange Book listings raises several possible hypotheses about the FTC's strategy and effectiveness, say Ratib Ali and Celia Lu at Competition Dynamics.
-
Unpacking Ore. Law's Limits On PE Healthcare Investment
A recent Oregon law imposes significant restrictions on nonphysicians owning or controlling medical practices, but newly enacted amendments provide some additional flexibility in certain ownership arrangements without scuttling the law's intent of addressing concerns about the rise of private equity investment in healthcare, say attorneys at Debevoise.
-
5 Ways Lawyers Can Earn Back The Public's Trust
Amid salacious headlines about lawyers behaving badly and recent polls showing the public’s increasingly unfavorable view of attorneys, we must make meaningful changes to our culture to rebuild trust in the legal system, says Carl Taylor at Carl Taylor Law.
-
Class Actions At The Circuit Courts: August Lessons
In this month's review of class action appeals, Mitchell Engel at Shook Hardy discusses key takeaways from federal appellate decisions involving topics including antitrust, immigration, consumer fraud, birthright citizenship under the Fourteenth Amendment, and product defects.
-
Series
Hiking Makes Me A Better Lawyer
On the trail, I have thought often about the parallels between hiking and high-stakes patent litigation, and why strategizing, preparation, perseverance and joy are important skills for success in both endeavors, says Barbara Fiacco at Foley Hoag.
-
Series
Law School's Missed Lessons: Negotiation Skills
I took one negotiation course in law school, but most of the techniques I rely on today I learned in practice, where I've discovered that the process is less about tricks or tactics, and more about clarity, preparation and communication, says Grant Schrantz at Haug Barron.
-
DOJ Whistleblower Program May Fuel Criminal Antitrust Tack
A recently launched Justice Department program that provides rewards for reporting antitrust crimes related to the U.S. Postal Service will serve to supplement the department’s leniency program, signaling an ambition to expand criminal enforcement while deepening collaboration across agencies, say attorneys at Crowell & Moring.
-
Opinion
Bar Exam Reform Must Expand Beyond A Single Updated Test
Recently released information about the National Conference of Bar Examiners’ new NextGen Uniform Bar Exam highlights why a single test is not ideal for measuring newly licensed lawyers’ competency, demonstrating the need for collaborative development, implementation and reform processes, says Gregory Bordelon at Suffolk University.
-
A Simple Way Courts Can Help Attys Avoid AI Hallucinations
As attorneys increasingly rely on generative artificial intelligence for legal research, courts should consider expanding online quality control programs to flag potential hallucinations — permitting counsel to correct mistakes and sparing judges the burden of imposing sanctions, say attorneys at Lankler Siffert & Wohl and Connors.